PMA P220006S005

Device
VENTANA FOLR1 (FOLR-2.1) RxDx Assay
Applicant
Ventana Medical Systems, Inc.
PMA number
P220006
Supplement
S005
Product code
QUL
Decision date
2024-01-26
Classification
Medical Genetics
Generic name
Immunohistochemistry Assay, Antibody, FOLR1
Approval order statement
approval for a change in expiry dating (extension to the stability from 12 months to 18 months) for Hematoxylin (PN 760-2021) and Hematoxylin II (PN 790-2208).

Current openFDA PMA Record#

Device
VENTANA FOLR1 (FOLR-2.1) RxDx Assay
Applicant
Ventana Medical Systems, Inc.
PMA number
P220006
Supplement
S005
Product code
QUL
Generic name
Immunohistochemistry Assay, Antibody, FOLR1
Decision date
2024-01-26
Decision code
APPR
Date received
2023-10-30
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
approval for a change in expiry dating (extension to the stability from 12 months to 18 months) for Hematoxylin (PN 760-2021) and Hematoxylin II (PN 790-2208).